Current Opinion in Infectious Diseases was launched in 1988. It is part of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The field of infectious diseases is divided into 11 sections that are reviewed once a year. Each section is assigned to a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Section Editors for this issue.
Barbara D. Alexander
Barbara D. Alexander, MD, MHS is Professor of Medicine and Pathology, Director of Transplant Infectious Disease (ID) Services, and Head of the Clinical Mycology Laboratory at Duke University in Durham, North Carolina, USA. Dr Alexander completed graduate studies at Duke where she honed her skills as a medical mycologist prior to receiving her medical degree from East Carolina University in Greenville, North Carolina, USA. She returned to Duke for internal medicine residency, infectious diseases and medical microbiology fellowships and obtained a Masters in Health Science in Clinical Research.
Dr Alexander has served on the Board of Directors for the Infectious Diseases Society of America (IDSA) for which she is currently President-Elect. She served as Associate Editor (2011–2016) then Associate Deputy Editor (2016–2020) for the Clinical Infectious Diseases journal and Chair (2014–17) of the Clinical and Laboratory Standards Institute Subcommittee on Antifungal Tests.
She is a National Institutes of Health-funded researcher, currently serving as Principal Investigator for the Duke University T32 multidisciplinary, institutional physician-scientist training program in Transplant ID. Her research efforts have led to standardized methods for susceptibility testing and interpretive breakpoints and epidemiologic cutoff values for fungi, FDA approval of new diagnostic tests and antifungal agents, as well as pivotal national epidemiologic investigations of fungal disease in transplant and immunocompromised host populations. She has also successfully collaborated with basic scientists to probe the molecular basis for fungal virulence and host susceptibility to invasive aspergillosis and candidemia. Dr Alexander has lectured nationally and internationally, has authored over 180 articles, book chapters, white papers and publications for mass distribution, and is considered a thought leader in the field of transplant ID.
Rachel A. Miller
Dr Rachel A. Miller, MD is Professor of Medicine at Duke University in Durham, North Carolina, USA. Dr Miller received her MD degree from the University of Iowa CCOM in Iowa City, Iowa, USA. She then completed residency training at the University of Texas Southwestern in Dallas, USA, before returning to the University of Iowa for Infectious Diseases fellowship training. She joined the University of Iowa faculty upon completion of her training.
From 1996 until February 2016, Dr Miller was a faculty member in the internal medicine department at the University of Iowa CCOM, with promotion to full professor in 2007. Upon joining the UI faculty in the mid-1990's, she founded the solid organ transplant ID consult service. Over time, this service developed into a long standing, successful clinical initiative in terms of optimizing patient care, achieving financial sustainability and providing educational opportunities. Medical education has been another major focus throughout her career, including her service as an Associate Residency Program Director in internal medicine for 12 years. She's had sustained involvement in scholarly projects and national committee work though the AST, IDSA and UNOS, largely related to the field of organ transplantation, throughout her career.
In March 2016, Dr Miller joined the Transplant ID faculty at Duke University, USA, where she continues with the clinical care of transplant recipients and is involved in several transplant associated clinical research studies, clinical operations leadership, and fellow/faculty mentoring. She recently served on the ID Week Program Committee for the IDSA from 2017–2019. Currently, she also serves as an Associate Editor for the American Journal of Transplantation. Dr Miller has consistently served as a lecturer at national and regional meetings and has authored over 35 articles, book chapters, and other publications for mass distribution.
Trish M. Perl
Dr Trish M. Perl is a Chief of Infectious Diseases and the Jay P Sanford Professor of Medicine at the University of Texas Southwestern, Dallas, Texas, USA. Prior to this appointment she was Professor in the Departments of Medicine (Infectious Diseases) and Pathology at Johns Hopkins University School of Medicine in Baltimore, Maryland, USA and in the Department of Epidemiology at the Johns Hopkins Bloomberg School of Public Health.
Dr Perl received her Bachelor of Arts and Medical Degree from the University of North Carolina at Chapel Hill, North Carolina, USA, and a Master of Science degree from McGill University in Montreal, Canada. She completed an internship, residency, and fellowship in internal medicine at McGill (Royal Victoria Hospital) and a fellowship in infectious diseases and clinical epidemiology at the University of Iowa Hospitals and Clinics in Iowa City, Iowa, USA. She was the hospital epidemiologist of the Johns Hopkins Hospital between 1996 and 2010.
She has extensive practical and research experience in the field of healthcare associated infections and resistant organisms and is world renowned for her innovation and research in the field and the application of research knowledge in the healthcare setting. Dr Perl was the 2006 President of the Society of Hospital Epidemiologists of America (SHEA). In the past, she has served on advisory panels for the Institute of Medicine (IOM), the Centers for Disease Control (CDC) and World Health Organization (WHO) and has been a consultant to the National Institutes of Health (NIH) and Agency for Healthcare Research and Quality (ARHQ). An active researcher, Dr Perl has been a principal and co-principal investigator for studies on healthcare associated infections, bioterrorism syndromic surveillance, respiratory infections and antimicrobial resistance for the Centers for Disease Control and Prevention. She has authored or co-authored over 220 peer-reviewed articles. In addition, she has written multiple chapters and contributed to guidelines and policies relevant to healthcare associated infections at the institutional, state and federal level.
Dr Perl has been funded by the Centers for Disease Control and Prevention, the Veteran's Affairs Administration and Industry over the years. Her scientific interests encompass emerging diseases and planning in healthcare facilities for their management, syndromic surveillance, respiratory infections, healthcare associated infections including surgical site infections, Clostridium difficile, emerging infection prevention and interventions to prevent, the transmission of epidemiologically significant organisms, and patient and healthcare worker safety. She is committed to training fellows and others with interests in healthcare epidemiology and has begun working in the developing world to help promote the science and discovery in infection prevention.